Targeting Aging with Metformin (TAME) trial is a double-blinded, placebo-controlled, multicenter trial that is planned to involve 14 research centers in the USA, and subject to funding and approval, will enroll 3000 ethnically diverse, non-diabetic subjects aged 6580 (261)
A note about Social Media : Opinions, comments and actions taken on Social Media are those of the third party and do not necessarily reflect the views of the creator of this profile or of the firm
The findings, published on June 5 in GLP-1 drugs, a class of blockbuster diabetes and obesity drugs sold under brand names like Ozempic and Wegovy, have surged in popularity in recent years
Folks may read that its okay to have a drink or two if they use an SSRI, but its important to remember that alcohol must be treated as a drug, Krinsky says
It may complicate the healing process, increasing the risk of scarring, hyperpigmentation, and inflammation
So, how effectively can we improve metabolic health using this exciting new nutraceutical GLP-1 agonist Eriomin
